Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.
about
Social Stress and Psychosis Risk: Common Neurochemical Substrates?Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severityBehavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.Salience attribution and its relationship to cannabis-induced psychotic symptoms.The effects of Δ9-tetrahydrocannabinol on the dopamine system.Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis usePreclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.Scientific Opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) in milk and other food of animal originDifferent effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats.Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.
P2860
Q30364687-43C9C2E3-D641-44BA-9539-CE3226DC52FDQ34002281-0C3EA438-C60A-4FFB-9FFB-17FD2AD8AC14Q35626928-B381E833-B719-4D7B-9C9F-C568A07C1784Q36610068-63287701-C23A-4C52-96B5-FB5A96FDE601Q36864001-146E340F-0A14-4C08-AF89-A44A3FD8AF8FQ37274656-48030C41-73FD-4EF4-8BD6-7AE3BEEA3EC1Q37437144-FC6ECD6B-88FB-4FCA-98A2-CAED90F422ABQ37441554-8AD45CDE-FD0C-4ABD-8C85-AA680B08B287Q37705759-7E12CFE1-F52C-47C3-A8FE-09366DBF5EF1Q38636791-3AA5A781-6FF8-40F3-A93C-2CD9195793FBQ38996589-0959572F-7DC2-401B-84FA-C27A89B61509Q44459554-241CE67B-34C6-4045-B66B-DFCD004B6027Q47157045-DBC37BDD-2C2B-4C46-A0A3-FECF611250ABQ47562104-8E4E2A0C-449E-4019-BB82-4C516DD0661BQ52625218-6A635C97-2634-44C5-8347-05F339E5EF5C
P2860
Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Chronic Δ⁹-tetrahydrocannabino ...... ens and nigrostriatal systems.
@ast
Chronic Δ⁹-tetrahydrocannabino ...... ens and nigrostriatal systems.
@en
type
label
Chronic Δ⁹-tetrahydrocannabino ...... ens and nigrostriatal systems.
@ast
Chronic Δ⁹-tetrahydrocannabino ...... ens and nigrostriatal systems.
@en
prefLabel
Chronic Δ⁹-tetrahydrocannabino ...... ens and nigrostriatal systems.
@ast
Chronic Δ⁹-tetrahydrocannabino ...... ens and nigrostriatal systems.
@en
P2093
P2860
P50
P921
P356
P1476
Chronic Δ⁹-tetrahydrocannabino ...... bens and nigrostriatal systems
@en
P2093
Nathalie Ginovart
Thierry Steimer
Vicente Ibanez
P2860
P2888
P304
P356
10.1038/NPP.2012.91
P407
P577
2012-06-13T00:00:00Z